Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.47 USD | +0.92% | +6.27% | +5.10% |
May. 17 | Sector Update: Health Care Stocks Softer Friday Afternoon | MT |
May. 17 | Doximity's Shares Rise After Truist Securities Price Target Raise Following Fiscal Q4 Results | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.44 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.10% | 5.46B | C+ | ||
+27.66% | 443B | B | ||
+31.75% | 276B | D+ | ||
+12.57% | 145B | A- | ||
+7.73% | 93.11B | C- | ||
+25.68% | 90.17B | B+ | ||
+64.02% | 61.13B | B- | ||
+14.54% | 46.32B | C+ | ||
+23.05% | 35.73B | C+ | ||
-12.79% | 31.13B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOCS Stock
- Ratings Doximity, Inc.